A turbulent 2024 for Neurocrine is ending on a high note, after the biotech won FDA approval to treat congenital adrenal ...

If its ITC power play is successful, the U.S. government will effectively be handing over another huge chunk of the American ...

As a result of the Sun Chemical v. Fike decisions, a carveout now exists for implied warranty claims that are based on a ...

The Biden administration is planning more policy actions related to artificial intelligence chips -- including possibly more export enforcement -- before President-elect Donald Trump takes over next ...